1. Home
  2. EAT vs GRFS Comparison

EAT vs GRFS Comparison

Compare EAT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinker International Inc.

EAT

Brinker International Inc.

HOLD

Current Price

$154.64

Market Cap

6.3B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.39

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EAT
GRFS
Founded
1975
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.8B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
EAT
GRFS
Price
$154.64
$8.39
Analyst Decision
Buy
Hold
Analyst Count
20
2
Target Price
$184.17
$10.15
AVG Volume (30 Days)
908.4K
733.5K
Earning Date
04-28-2026
07-28-2022
Dividend Yield
N/A
1.70%
EPS Growth
144.71
N/A
EPS
5.03
N/A
Revenue
$5,384,200,000.00
N/A
Revenue This Year
$9.02
$4.69
Revenue Next Year
$5.45
$6.49
P/E Ratio
$30.60
$18.67
Revenue Growth
21.95
N/A
52 Week Low
$100.30
$6.58
52 Week High
$187.12
$11.14

Technical Indicators

Market Signals
Indicator
EAT
GRFS
Relative Strength Index (RSI) 59.19 55.02
Support Level $150.46 $8.25
Resistance Level $169.95 $9.11
Average True Range (ATR) 6.08 0.21
MACD 1.62 0.12
Stochastic Oscillator 81.46 96.60

Price Performance

Historical Comparison
EAT
GRFS

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: